The Oncosearch | Oncotarget

ACSL4: biomarker, mediator and target in quadruple negative breast cancer Review

Marie E. Monaco

Published Jun 5, 2023 · Vol. 14, No. 1 · pp. 563-575

Keywords: ACSL4, breast cancer, ferroptosis, molecular subtype, quadruple negative breast cancer

Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment Research Paper

Valentin Feichtenschlager, Yixuan James Zheng, Wilson Ho, Linan Chen, Ciara Callanan, Christopher Chen, Albert Lee, Jose Ortiz, Klemens Rappersberger, Susana Ortiz-Urda

Published May 19, 2023 · Vol. 14, No. 1 · pp. 543-560

Keywords: MALAT1, MAPK-pathway, BRAF, melanoma, antisense oligonucleotides

Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression Research Paper

Mohammad Salman Akhtar, Naseem Akhter, Arshi Talat, Raed A. Alharbi, Abdulmajeed A.A. Sindi, Faisal Klufah, Hanan E. Alyahyawi, Abdulmohsen Alruwetei, Abrar Ahmad, Mazin A. Zamzami, SVS Deo, Syed Akhtar Husain, Osama A. Badi, Mohammad Jahir Khan

Published May 16, 2023 · Vol. 14, No. 1 · pp. 528-541

Keywords: BORIS, breast cancer, mutation, transcription factor, PCR-SSCP

Role of creatine shuttle in colorectal cancer cells Research Paper

Mayu Kita, Rina Fujiwara-Tani, Shingo Kishi, Shiori Mori, Hitoshi Ohmori, Chie Nakashima, Kei Goto, Takamitsu Sasaki, Kiyomu Fujii, Isao Kawahara, Ujjal Kumar Bhawal, Yi Luo, Hiroki Kuniyasu

Published May 12, 2023 · Vol. 14, No. 1 · pp. 485-501

Keywords: creatine kinase B, mitochondrial creatine kinase, ATP metabolism, phosphorylation signal, stemness

Targeting the Src N-terminal regulatory element in cancer Research Perspective

Betlem Mezquita, Marjorie Reyes-Farias, Miquel Pons

Published May 12, 2023 · Vol. 14, No. 1 · pp. 503-513

Keywords: Src family kinases, intrinsically disordered proteins, SNRE, cell-type selective drugs, drug resistance

G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis Research Paper

Monalisa Parija, Amit K. Adhya, Sandip K. Mishra

Published May 11, 2023 · Vol. 14, No. 1 · pp. 466-480

Keywords: G-protein-coupled receptor 141, cell migration, metastasis, p-mTOR, p53

Correction: A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling Correction

Stephan J. Matissek, Mona Karbalivand, Weiguo Han, Ava Boutilier, Estefania Yzar-Garcia, Laura L. Kehoe, Devin Storm Gardner, Adam Hage, Krista Fleck, Vicki Jeffers, Ricardo Rajsbaum, Sherine F. Elsawa

Published May 10, 2023 · Vol. 14, No. 1 · pp. 448-448

A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850 Research Paper

Kristen R. Spencer, Daniella E. Portal, Joseph Aisner, Mark N. Stein, Jyoti Malhotra, Weichung Shih, Nancy Chan, Ann W. Silk, Shridar Ganesan, Susan Goodin, Murugesan Gounder, Hongxia Lin, Jiadong Li, Robert Cerchio, Christina Marinaro, Suzie Chen, Janice M. Mehnert

Published Apr 3, 2023 · Vol. 14, No. 1 · pp. 302-315

Keywords: GRM1, riluzole, sorafenib, phase I, clinical trial

Correction: Calcitonin receptor is required for T-antigen-induced prostate carcinogenesis Correction

Ajay Kale, Afaf Aldahish, Girish Shah

Published Mar 23, 2023 · Vol. 14, No. 1 · pp. 316-316

Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors Editorial

Giulia Franciosa, Jesper V. Olsen

Published Mar 21, 2023 · Vol. 14, No. 1 · pp. 281-283

Keywords: SHP2, PTPN11, tyrosine, phosphorylation

AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function Editorial

Till Braun, Hanna Klepzig, Marco Herling

Published Feb 28, 2023 · Vol. 14, No. 1 · pp. 395-397

Keywords: T-PLL, AGO2, microRNA

Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability Research Paper

Clark G. Wang, Malalage N. Peiris, April N. Meyer, Katelyn N. Nelson, Daniel J. Donoghue

Published Feb 6, 2023 · Vol. 14, No. 1 · pp. 133-145

Keywords: oncogenic fusion protein, chromosomal translocation, glioblastoma, FGFR3-TACC3, coiled-coil

The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy Research Perspective

Anqi Shao, David M. Owens

Published Jan 27, 2023 · Vol. 14, No. 1 · pp. 96-103

Keywords: CD200 receptor, oncoimmunology, immunotherapy, tumor microenvironment, immune checkpoint inhibition

Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer Research Paper

Romana Moench, Martin Gasser, Karol Nawalaniec, Tanja Grimmig, Amrendra K. Ajay, Larissa Camila Ribeiro de Souza, Minghua Cao, Yueming Luo, Petra Hoegger, Carmen M. Ribas, Jurandir M. Ribas-Filho, Osvaldo Malafaia, Reinhard Lissner, Li-Li Hsiao, Ana Maria Waaga-Gasser

Published Oct 6, 2022 · Vol. 13, No. 1 · pp. 1140-1152

Keywords: PDGF, VEGFR, EGFR, bypassed signaling, colorectal cancer

Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma Research Paper

Aayush Aayush, Saloni Darji, Deepika Dhawan, Alexander Enstrom, Meaghan M. Broman, Muhammad T. Idrees, Hristos Kaimakliotis, Timothy Ratliff, Deborah Knapp, David Thompson

Published Aug 27, 2022 · Vol. 13, No. 1 · pp. 1004-1016

Keywords: bladder cancer, elastin-like polypeptide, NIR imaging, epidermal growth factor receptor (EGFR), translational studies

Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer Addendum

Sewanti Limaye, Prashant Kumar, Ramya Pragya, Janani Sambath, Darshana Patil, Ajay Srinivasan, Sachin Apurva, Navin Srivastava, Sanket Patil, Revati Patil, Vineet Datta, Dadasaheb Akolkar, Rajan Datar

Published Aug 4, 2022 · Vol. 13, No. 1 · pp. 982-982

A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling Priority Research Paper

Stephan J. Matissek, Mona Karbalivand, Weiguo Han, Ava Boutilier, Estefania Yzar-Garcia, Laura L. Kehoe, Devin Storm Gardner, Adam Hage, Krista Fleck, Vicki Jeffers, Ricardo Rajsbaum, Sherine F. Elsawa

Published Jul 29, 2022 · Vol. 13, No. 1 · pp. 944-959

Keywords: GLI3, inflammation, TLR

Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma Research Paper

Sujatha Muralidharan, Thibault Kervarrec, Glen J. Weiss, Mahtab Samimi

Published Jul 20, 2022 · Vol. 13, No. 1 · pp. 960-967

Keywords: Merkel cell carcinoma, glypican-3, Merkel cell polyomavirus, outcome

Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation Research Paper

Raquel Torres-Guzmán, Maria Patricia Ganado, Cecilia Mur, Carlos Marugan, Carmen Baquero, Yanzhu Yang, Yi Zeng, Huimin Bian, Jian Du, Alfonso de Dios, Oscar Puig, María José Lallena

Published Jun 22, 2022 · Vol. 13, No. 1 · pp. 864-875

Keywords: abemaciclib, breast cancer, cell lines, CDK4/6, continuous dosing

Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II Correction

Suparna Mazumder, Valerie Swank, Anton A. Komar, Justin M. Johnson, Vincent K. Tuohy

Published Jun 9, 2022 · Vol. 13, No. 1 · pp. 905-906

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

ACSL4: biomarker, mediator and target in quadruple negative breast cancer Review

Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment Research Paper

Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression Research Paper

Role of creatine shuttle in colorectal cancer cells Research Paper

Targeting the Src N-terminal regulatory element in cancer Research Perspective

G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis Research Paper

Correction: A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling Correction

A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850 Research Paper

Correction: Calcitonin receptor is required for T-antigen-induced prostate carcinogenesis Correction

Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors Editorial

AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function Editorial

Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability Research Paper

The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy Research Perspective

Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer Research Paper

Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma Research Paper

Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer Addendum

A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling Priority Research Paper

Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma Research Paper

Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation Research Paper

Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II Correction

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

ACSL4: biomarker, mediator and target in quadruple negative breast cancer Review

Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment Research Paper

Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression Research Paper

Role of creatine shuttle in colorectal cancer cells Research Paper

Targeting the Src N-terminal regulatory element in cancer Research Perspective

G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis Research Paper

Correction: A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling Correction

A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850 Research Paper

Correction: Calcitonin receptor is required for T-antigen-induced prostate carcinogenesis Correction

Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors Editorial

AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function Editorial

Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability Research Paper

The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy Research Perspective

Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer Research Paper

Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma Research Paper

Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer Addendum

A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling Priority Research Paper

Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma Research Paper

Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation Research Paper

Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II Correction